Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Raffinose-Carboxymethyl Cellulose Hydrogel, Silk Fibroin, and Agbtc Mof: A Nanobiocomposite With Biomedical Applications Publisher



Nia SM1 ; Naderi N1 ; Aliabadi HAM2 ; Kashtiaray A1 ; Mahdavi M3 ; Eivazzadehkeihan R4 ; Maleki A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, 16846-13114, Iran
  2. 2. Advanced Chemical Studies Lab, Department of Chemistry, K. N. Toosi University of Technology, Tehran, Iran
  3. 3. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Nanobiotechnology Department, New Technologies Research Group, Pasteur Institute of Iran, Tehran, Iran

Source: Cellulose Published:2024


Abstract

Natural polymer-based hydrogels have importance in tissue engineering, drug delivery systems, and wound dressings due to their non-toxicity, renewability, biocompatibility, and biodegradability. Also, hydrogels can be modified to increase their antibacterial activity and mechanical properties. In this study, a novel nanobiocomposite was fabricated using raffinose (Raff)-carboxymethyl cellulose (CMC) hydrogel, silk fibroin (SF), and AgBTC metal organic framework (MOF). The nanobiocomposite was characterized using Fourier transform infrared (FT-IR), field emission scanning electron microscopy (FE-SEM), energy dispersive X-ray (EDX), thermogravimetric analysis (TGA), and X-ray diffraction (XRD) analyses. After 48 h of incubation, the (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) (MTT) assay of Raff-CMC hydrogel/SF/AgBTC nanobiocomposite on HEK293T cells (human embryonic healthy kidney cell lines) and MCF-7 cells (human breast cancer cell lines) showed that the percentage of cell viability of the two cell lines was 90.46% and 29.18%, respectively. The measured hemolytic activity of the nanobiocomposite on human red blood cells was 2.39%, indicating its safety for use in the human circulatory system, as it did not cause significant hemolysis in erythrocytes compared to the negative control. The potential of the Raff-CMC hydrogel/SF/AgBTC nanobiocomposite to inhibit bacterial growth was investigated, and results showed that E. coli and S. aureus growth was restricted by 60.38% and 57.09%, respectively. As a result, considering the biocompatibility of nanobiocomposite with healthy cells, its antibacterial and anticancer activity, as well as its hemocompatibility, it can be considered a potential candidate for biomedical applications such as wound healing, tissue engineering, and cancer therapy. © The Author(s), under exclusive licence to Springer Nature B.V. 2024.
Other Related Docs
16. Recent Advances on Biomedical Applications of Pectin-Containing Biomaterials, International Journal of Biological Macromolecules (2022)